These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31338629)

  • 1. Experience of the use of octreotide for refractory gastrointestinal bleeding in a patient with Jarvik2000
    Nakajima-Doi S; Seguchi O; Shintani Y; Fujita T; Fukushima S; Matsumoto Y; Eura Y; Kokame K; Miyata S; Matsuda S; Mochizuki H; Iwasaki K; Kimura Y; Toda K; Kumai Y; Kuroda K; Watanabe T; Yanase M; Kobayashi J; Fukushima N
    J Artif Organs; 2019 Dec; 22(4):334-337. PubMed ID: 31338629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities.
    Molina TL; Krisl JC; Donahue KR; Varnado S
    ASAIO J; 2018; 64(4):433-439. PubMed ID: 29406356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the severity of acquired von Willebrand syndrome and gastrointestinal bleeding after continuous-flow left ventricular assist device implantation.
    Sakatsume K; Saito K; Akiyama M; Sasaki K; Kawatsu S; Takahashi G; Adachi O; Kawamoto S; Horiuchi H; Saiki Y
    Eur J Cardiothorac Surg; 2018 Nov; 54(5):841-846. PubMed ID: 29741685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
    Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
    ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Sieg AC; Moretz JD; Horn E; Jennings DL
    Pharmacotherapy; 2017 Nov; 37(11):1432-1448. PubMed ID: 28833332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System.
    Goldstein DJ; Aaronson KD; Tatooles AJ; Silvestry SC; Jeevanandam V; Gordon R; Hathaway DR; Najarian KB; Slaughter MS;
    JACC Heart Fail; 2015 Apr; 3(4):303-13. PubMed ID: 25770405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
    Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
    ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding.
    Kim JH; Brophy DF; Shah KB
    Cardiol Clin; 2018 Nov; 36(4):519-529. PubMed ID: 30297069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device.
    Juricek C; Imamura T; Nguyen A; Chung B; Rodgers D; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Burkhoff D; Sayer G; Jeevanandam V; Uriel N
    J Card Fail; 2018 Apr; 24(4):249-254. PubMed ID: 29427603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding.
    Shah KB; Gunda S; Emani S; Kanwar MK; Uriel N; Colombo PC; Uber PA; Sears ML; Chuang J; Farrar DJ; Brophy DF; Smallfield GB
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices.
    Malhotra R; Shah KB; Chawla R; Pedram S; Smallfield MC; Priday AG; DeWilde CT; Brophy DF
    ASAIO J; 2017; 63(3):367-370. PubMed ID: 27922890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal Bleeding Rates in Left Ventricular Assist Device Population Reduced with Octreotide Utilization.
    Wilson TJ; Baran DA; Herre JM; Cameron CM; Yehya A; Ingemi AI
    ASAIO J; 2021 Sep; 67(9):989-994. PubMed ID: 33369929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management.
    Tabibian JH; Rhoades DP; Forde KA; McLean RC; Chandrasekhara V
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):448-454. PubMed ID: 29906524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patients.
    Seng BJJ; Teo LLY; Chan LL; Sim DKL; Kerk KL; Soon JL; Tan TE; Sivathasan C; Lim CP
    Int J Artif Organs; 2017 Oct; 40(11):636-640. PubMed ID: 28708213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin Is Associated With a Decreased Incidence of Angiodysplasia-Related Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Vukelic S; Vlismas PP; Patel SR; Xue X; Shitole SG; Saeed O; Sims DB; Chinnadurai T; Shin JJ; Forest SJ; Goldstein DJ; Jorde UP
    Circ Heart Fail; 2018 Aug; 11(8):e004899. PubMed ID: 30354557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between novel clinical factors and gastrointestinal bleeding among patients supported with continuous-flow left ventricular assist device therapy.
    Thohan V; Shi Y; Rappelt M; Yousefzai R; Sulemanjee NZ; Hastings TE; Cheema OM; Downey F; Crouch JD
    J Card Surg; 2019 Jun; 34(6):453-462. PubMed ID: 31058372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cessation of Continuous Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding After Heart Transplantation.
    Patel SR; Oh KT; Ogriki T; Sims D; Shin JJ; Madan S; Saeed O; Goldstein DJ; Jorde UP
    ASAIO J; 2018; 64(2):191-195. PubMed ID: 28665827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.